logo
Plus   Neg
Share
Email

Dynatrace Boosts FY21 Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, software intelligence provider Dynatrace, Inc. (DT) raised its adjusted earnings and revenue guidance for the full-year 2021 and provided outlook for the second quarter.

For fiscal 2021, the company now projects adjusted earnings in a range of $0.46 to $0.49 per share on total revenues between $646.0 million and $656.0 million, with 17 to 20 percent growth in constant currency.

Previously, the company expected adjusted earnings in the range of $0.39 to $0.42 per share on total revenues between $630.0 million and $643.0 million.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $0.41 per share on revenues of $640.59 million for the year. Analysts' estimates typically exclude special items.

For the second quarter, the company projects adjusted earnings in the range of $0.09 to $0.10 per share on total revenues between $159.0 million and $161.0 million. The Street is looking for earnings of $0.10 per share on revenues of $154.25 million for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement. Supermarket chain Wegmans Food Markets, Inc. is recalling select Valencia oranges, lemons, and various other products containing fresh lemon citing potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration announced. The recall was initiated after Wegmans' lemons and oranges supplier Freshouse Produce LLC, issued a recall of its supplies.
RELATED NEWS
Follow RTT